Community News · Pullman, WA
Pullman-based SEL Launches Autism Screening Device Clinical Trial in Lewiston, Moscow and Pullman
Pullman, Washington-based Schweitzer Engineering Laboratories announced a clinical trial Monday, Nov. 16, 2026, to evaluate APS Detect, an investigational handheld pupillometer that measures children's pupil response to light to help clinicians identify children who may need further autism spectrum disorder evaluation. The study lists four sites — SEL Health Clinics in Lewiston and Pullman and Palouse Pediatrics offices in Moscow and Pullman — began in October 2026 and is expected to run into 2027, comparing device results with established clinical assessments and testing consistency across clinicians. The device grew out of research by Dr. Georgina Lynch at Washington State University; SEL said in January 2025 it planned to manufacture the technology. SEL said the device is not FDA-cleared for clinical use; families can find details and eligibility criteria on ClinicalTrials.gov.